Retasturtide is a recently developed novel GLP-1 receptor agonist demonstrating encouraging results in the control of type 2 diabetes. This synthetic peptide resembles the actions of naturally present GLP-1, a hormone https://socialmediainuk.com/story25142299/retasturtide-a-novel-glp-1-receptor-agonist-for-type-2-diabetes